118 related articles for article (PubMed ID: 18715816)
1. Apoptotic effect of CKD-602 (Camtobell) on oral squamous cell carcinoma cell lines.
Ok YJ; Myoung H; Kim YK; Lee JH; Kim MJ; Yun PY
Oral Oncol; 2009 Mar; 45(3):266-72. PubMed ID: 18715816
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by paclitaxel in human oral carcinoma cells.
Nonaka M; Ikeda H; Fujisawa A; Uehara M; Inokuchi T
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):649-52. PubMed ID: 16513327
[TBL] [Abstract][Full Text] [Related]
3. Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2/Bax.
Tian X; Zeng G; Li X; Wu Z; Wang L
Oncol Rep; 2015 Jun; 33(6):3061-8. PubMed ID: 25962755
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
[TBL] [Abstract][Full Text] [Related]
5. Mithramycin A inhibits myeloid cell leukemia-1 to induce apoptosis in oral squamous cell carcinomas and tumor xenograft through activation of Bax and oligomerization.
Shin JA; Jung JY; Ryu MH; Safe S; Cho SD
Mol Pharmacol; 2013 Jan; 83(1):33-41. PubMed ID: 23019217
[TBL] [Abstract][Full Text] [Related]
6. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway.
Lin CC; Yang JS; Chen JT; Fan S; Yu FS; Yang JL; Lu CC; Kao MC; Huang AC; Lu HF; Chung JG
Anticancer Res; 2007; 27(5A):3371-8. PubMed ID: 17970083
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and expression of Bax and Bcl-2 in snuff- and non-snuff associated oral squamous cell carcinomas.
Loro LL; Vintermyr OK; Ibrahim SO; Idris AM; Johannessen AC
Anticancer Res; 2000; 20(5A):2855-60. PubMed ID: 11062693
[TBL] [Abstract][Full Text] [Related]
8. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
9. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
[TBL] [Abstract][Full Text] [Related]
10. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.
Guo B; Cao S; Tóth K; Azrak RG; Rustum YM
Clin Cancer Res; 2000 Feb; 6(2):718-24. PubMed ID: 10690558
[TBL] [Abstract][Full Text] [Related]
12. Oral cancer-associated fibroblasts inhibit heat-induced apoptosis in Tca8113 cells through upregulated expression of Bcl-2 through the Mig/CXCR3 axis.
Bian L; Sun X; Jin K; He Y
Oncol Rep; 2012 Dec; 28(6):2063-8. PubMed ID: 22961626
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Bax in oral SCC in relation to antitumor effects of chemotherapy.
Takemura K; Noguchi M; Ogi K; Tokino T; Kubota H; Miyazaki A; Kohama G; Hiratsuka H
J Oral Pathol Med; 2005 Feb; 34(2):93-9. PubMed ID: 15641988
[TBL] [Abstract][Full Text] [Related]
14. The dietary phytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, and p53 signaling.
Weng JR; Bai LY; Chiu CF; Wang YC; Tsai MH
Chem Biol Interact; 2012 Feb; 195(3):224-30. PubMed ID: 22290291
[TBL] [Abstract][Full Text] [Related]
15. [Effects and mechanism of lutein on apoptosis of esophageal carcinoma EC9706 cells].
Pei YX; Heng ZC; Duan GC; Zhang ZZ; Wang MC; Hu CL; Gao DL
Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(4):332-4, 354. PubMed ID: 17455471
[TBL] [Abstract][Full Text] [Related]
16. The role of p53 status on the synergistic effect of CKD-602 and cisplatin on oral squamous cell carcinoma cell lines.
Choi HS; Kim YK; Yun PY
Mol Biol Rep; 2019 Feb; 46(1):617-625. PubMed ID: 30478746
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
Wang C; Guo LB; Ma JY; Li YM; Liu HM
Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
[TBL] [Abstract][Full Text] [Related]
18. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
19. Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression.
Liu MD; Xiong SJ; Tan F; Liu Y
Acta Pharmacol Sin; 2016 May; 37(5):687-97. PubMed ID: 27063218
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of combined use of cyclopamine and hydroxycamptothecin in inducing the apoptosis of human oral squamous cell carcinoma cell line].
Jiang S; Chen XL; Ding Y; Chen ZW; Zhu LJ; Feng H; Wang QM; Zhen MC; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1034-6. PubMed ID: 20501387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
